Oxford Nanopore Technologies
Pioneering life sciences company that develops and commercializes nanopore-based DNA and RNA sequencing technology, enabling real-time, long-read sequencing in portable formats.
Website
https://www.nanoporetech.comLocation
Oxford, United Kingdom
Founded
2005
Investors
1
Categories
genomics-sequencing, biotech, diagnostics, nanopore-technology
Notes
Oxford Nanopore Technologies is a pioneering life sciences company that has developed a new generation of nanopore-based sensing technology for DNA and RNA sequencing. The company's technology enables real-time, long-read sequencing in devices ranging from portable pocket-sized sequencers (MinION) to high-throughput systems (PromethION).
Oxford Nanopore's technology is unique in its ability to sequence native DNA and RNA without amplification, providing real-time results and enabling applications from research to clinical diagnostics and point-of-care testing.
Team
- Gordon Sanghera, Ph.D. - Chief Executive Officer
- LinkedIn: linkedin.com/in/gordon-sanghera
- Clive Brown - Chief Technology Officer
Additional Research Findings
- Founded in 2005 in Oxford, UK
- Listed on London Stock Exchange (ticker: ONT)
- Novo Holdings invested £50 million (August 2024)
- Proprietary nanopore sequencing technology
- Products include MinION (portable), GridION, and PromethION platforms
- Real-time sequencing capability
- Applications in research, clinical diagnostics, and pathogen surveillance
- Used in COVID-19 pandemic response for variant tracking
- Long-read sequencing complements short-read technologies
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Novo Holdings | Hellerup, Denmark | biotech-focused | seedseries-a+3 | 13 |